LAUSR

1. Berger VW, Alperson SY. A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials 2009;4:79‐88. 2. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332. 3. Hempel S, Suttorp MJ, Miles JNV, Wang Z, Maglione M, Morton S, et al. Empirical Evidence of Associations Between Trial Quality and Effect Size. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun. [Table], Jadad Scale. Available from: https:// www.ncbi.nlm.nih.gov/books/NBK56923/table/appendixes.app6. t1/. [Last accessed on 2021 Dec 18]. 4. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1‐12. 5. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, et al. The Delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235‐41. 6. Nasa P, Jain R, Juneja D. Delphi methodology in healthcare research: How to decide its appropriateness. World J Methodol 2021;11:116‐29. 7. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‐NonCommercial‐ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non‐commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.